IDT opens new manufacturing facility to expand capacity of COVID-19 products

Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced the opening of its new manufacturing facility located in the Research Triangle Park in North Carolina. The facility expands IDT’s manufacturing capabilities and will offer industry-leading turnaround time of its product portfolio to the eastern portion of the United States. In response to the COVID-19 pandemic, IDT has prepared the North Carolina facility to first manufacture products to support our customers’ efforts related to COVID-19 testing and research.

IDT’s primers and probes are important components of COVID-19 tests. The Company has produced primer and probe kits sufficient to enable more than 31 million tests to be conducted in the United States pursuant to the CDC EUA testing protocol. The new North Carolina facility further expands IDT’s capacity to serve customers and meet demand.

Widely recognized as the industry leader in DNA writing, IDT will offer custom oligonucleotides at the North Carolina facility with longer available sequence lengths and more available modifications than any other manufacturer in the region. These product options, combined with a turnaround time that can get orders into customers hands as quickly as the next day, allows researchers to start projects sooner while taking advantage of IDT’s signature product quality.

The facility is the latest addition in IDT’s continued global expansion, joining production facilities in Coralville, Iowa, USA; San Diego, California, USA; Leuven, Belgium; and Singapore. IDT services researchers in more than 100 countries from these locations. The North Carolina facility has been equipped with IDT’s proprietary machinery and manufacturing processes, ensuring that products have the same high level of quality and consistency as those produced at all other facilities.

The launch of our North Carolina Facility allows IDT to offer the best speed of service for East Coast and other markets, while maintaining our industry-leading product quality and 100% quality control. The added demand for Coronavirus-specific products means this is an opportune time for us to add new capacity, which has been configured specifically for this important purpose.  The new facility will therefore immediately increase IDT’s capability to manufacture products that enable more COVID-19 testing.”

Trey Martin, IDT President

In addition to serving customers in Research Triangle Park, the North Carolina facility will support next-day service to a number of cities, including Baltimore, Boston, Houston, New York City, and Philadelphia. Researchers will be able to order custom oligos up until 8:00 PM and receive them the following day with no additional fees.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Integrated DNA Technologies. (2020, May 18). IDT opens new manufacturing facility to expand capacity of COVID-19 products. News-Medical. Retrieved on October 24, 2020 from https://www.news-medical.net/news/20200518/IDT-opens-new-manufacturing-facility-to-expand-capacity-of-COVID-19-products.aspx.

  • MLA

    Integrated DNA Technologies. "IDT opens new manufacturing facility to expand capacity of COVID-19 products". News-Medical. 24 October 2020. <https://www.news-medical.net/news/20200518/IDT-opens-new-manufacturing-facility-to-expand-capacity-of-COVID-19-products.aspx>.

  • Chicago

    Integrated DNA Technologies. "IDT opens new manufacturing facility to expand capacity of COVID-19 products". News-Medical. https://www.news-medical.net/news/20200518/IDT-opens-new-manufacturing-facility-to-expand-capacity-of-COVID-19-products.aspx. (accessed October 24, 2020).

  • Harvard

    Integrated DNA Technologies. 2020. IDT opens new manufacturing facility to expand capacity of COVID-19 products. News-Medical, viewed 24 October 2020, https://www.news-medical.net/news/20200518/IDT-opens-new-manufacturing-facility-to-expand-capacity-of-COVID-19-products.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
IDT releases new ultra-high performance CRISPR Cas12a enzyme